Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 7 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOWERS, ERIN M | 2 | 54.7% | +10.6% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.6% |
| PAK, YONG D | 1 | 74.6% | +14.3% |
| BRADY, KRISTEN WEEKS | 1 | 0.0% | +0.0% |
| MISHRA, DEEPA | 1 | 29.3% | +35.2% |
| RILEY, JEZIA | 1 | 82.9% | +7.3% |
| WARD, PAUL V | 1 | 83.2% | -12.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176918 | NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF | RILEY, JEZIA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18655005 | COMPLEMENTATION-BASED TAGS AND REPORTERS FOR DUAL-MODALITY LABELING | BOWERS, ERIN M | — |
| 18595339 | ENGINEERED DNA POLYMERASE WITH REDUCED ARTIFACT FORMATION | PAK, YONG D | — |
| 18486892 | COELENTERAZINE ANALOGUES | BRADY, KRISTEN WEEKS | — |
| 18457679 | RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER | MISHRA, DEEPA | — |
| 18169326 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | WARD, PAUL V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18812371 | ENHANCEMENT OF KINASE TARGET ENGAGEMENT | STEADMAN, DAVID J | — |
| 18655005 | COMPLEMENTATION-BASED TAGS AND REPORTERS FOR DUAL-MODALITY LABELING | BOWERS, ERIN M | — |
| 18595339 | ENGINEERED DNA POLYMERASE WITH REDUCED ARTIFACT FORMATION | PAK, YONG D | — |
| 18457679 | RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER | MISHRA, DEEPA | — |
| 18312117 | SPLIT MODIFIED DEHALOGENASE VARIANTS | BOWERS, ERIN M | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 1656 | 1 |
| 1683 | 1 |
| 1692 | 1 |
| 1657 | 1 |
| 1681 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18812371 | ENHANCEMENT OF KINASE TARGET ENGAGEMENT | STEADMAN, DAVID J | 1656 | §103DPOther | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18655005 | COMPLEMENTATION-BASED TAGS AND REPORTERS FOR DUAL-MODALITY LABELING | BOWERS, ERIN M | 1653 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18595339 | ENGINEERED DNA POLYMERASE WITH REDUCED ARTIFACT FORMATION | PAK, YONG D | 1683 | §101§102§103§112DP | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18486892 | COELENTERAZINE ANALOGUES | BRADY, KRISTEN WEEKS | 1692 | §103 | Final Rejection | — | Pending | Oct 13, 2023 |
| 18457679 | RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER | MISHRA, DEEPA | 1657 | §103§112 | Non-Final OA | — | Pending | Aug 29, 2023 |
| 18312117 | SPLIT MODIFIED DEHALOGENASE VARIANTS | BOWERS, ERIN M | 1653 | §103 | Non-Final OA | — | Pending | May 04, 2023 |
| 18176918 | NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF | RILEY, JEZIA | 1681 | §102§112DP | Non-Final OA | — | Pending | Mar 01, 2023 |
| 18169326 | OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS | WARD, PAUL V | 1622 | §103§112 | Non-Final OA | — | Pending | Feb 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial